Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies

Journal of Proteome Research

Volumn 11, Issue 8, 2012, Pages 3986-3995

  Prakash, Amol ^a   Rezai, Taha ^a   Krastins, Bryan ^a   Sarracino, David ^a   Athanas, Michael ^a   Russo, Paul ^b   Zhang, Hui ^c   Tian, Yuan ^c   Li, Yan ^d   Kulasingam, Vathany ^e   Drabovich, Andrei ^e   Smith, Christopher R ^e   Batruch, Ihor ^e   Oran, Paul E ^f   Fredolini, Claudia ^b   Luchini, Alessandra ^b   Liotta, Lance ^b   Petricoin, Emanuel ^b   Diamandis, Eleftherios P ^e   Chan, Daniel W ^c   Nelson, Randall ^f   Lopez, Mary F ^a   more..

^a Thermo Fisher Scientific   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d INSTITUTE OF BIOPHYSICS   (China)

^e UNIVERSITY OF TORONTO   (Canada)

^f ARIZONA STATE UNIVERSITY   (United States)

Author keywords

clinical assay; mass spectrometry; proteomics; SRM assay

Indexed keywords

GLYCOSYLATED PROTEIN; GROWTH HORMONE; PROSTATE SPECIFIC ANTIGEN; SEMINAL PLASMA PROTEIN; TRYPSIN;

AMINO ACID SEQUENCE; ARTICLE; BODY FLUID; DIGESTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOASSAY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MASS SPECTROMETRY SELECTIVE REACTION MONITORING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; REPRODUCIBILITY;

AMINO ACID SEQUENCE; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, REVERSE-PHASE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; LABORATORIES; LIMIT OF DETECTION; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SEMINAL PLASMA PROTEINS;

EID: 84864583363     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300014s     Document Type: Article

References (46)

1. Anderson, N. L. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum Clin. Chem. 2010, 56 (2) 177-185
2. Hoofnagle, A. N.; Wener, M. H. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry J. Immunol. Methods 2009, 347, 3-11
3. Agger, S. A.; Marney, L. C.; Hoofnagle, A. N. Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry Clin. Chem. 2010, 56 (12) 1804-1813
4. Fu, Q; Schoenhoff, F. S.; Savage, W. J.; Zhang, P.; Van Eyk, J. E. Multiplex assays for biomarker research and clinical application: translational science coming of age Proteomics Clin. Appl. 2010, 4 (3) 271-284
5. Borges, C. R.; Rehder, D. S.; Jarvis, J. W.; Schaab, M. R.; Oran, P. E.; Nelson, R. W. Full-length characterization of proteins in human populations Clin. Chem. 2010, 6, 202-211
6. Miller, W. L.; Phelps, M. A.; Wood, C. M.; Schellenberger, U.; Van Le, A.; Perichon, R.; Jaffe, A. S. Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure Circ.: Heart Failure 2011, 4 (3) 355-360
7. Vogeser, M.; Seger, C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory Clin. Chem. 2010, 56 (8) 1234-1244
8. Addona, T. A.; Abbatiello, S. E.; Schilling, B.; Skates, S. J.; Mani, D. R.; Bunk, D. M.; Spiegelman, C. H.; Zimmerman, L. J.; Ham, A. J.; Keshishian, H.; Hall, S. C.; Allen, S.; Blackman, R. K.; Borchers, C. H.; Buck, C.; Cardasis, H. L.; Cusack, M. P.; Dodder, N. G.; Gibson, B. W.; Held, J. M.; Hiltke, T.; Jackson, A.; Johansen, E. B.; Kinsinger, C. R.; Li, J.; Mesri, M.; Neubert, T. A.; Niles, R. K.; Pulsipher, T. C.; Ransohoff, D.; Rodriguez, H.; Rudnick, P. A.; Smith, D.; Tabb, D. L.; Tegeler, T. J.; Variyath, A. M.; Vega-Montoto, L. J.; Wahlander, A.; Waldemarson, S.; Wang, M.; Whiteaker, J. R.; Zhao, L.; Anderson, N. L.; Fisher, S. J.; Liebler, D. C.; Paulovich, A. G.; Regnier, F. E.; Tempst, P.; Carr, S. A. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma Nat. Biotechnol. 2009, 27 (7) 633-641
9. Prakash, A.; Rezai, T.; Krastins, B.; Sarracino, D.; Athanas, M.; Russo, P.; Ross, M. M.; Zhang, H.; Tian, Y.; Kulasingam, V.; Drabovich, A. P.; Smith, C.; Batruch, I.; Liotta, L.; Petricoin, E.; Diamandis, E. P.; Chan, D. W.; Lopez, M. F. A platform for establishing inter-laboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays J Proteome Res. 2010, 9, 6678-6688
10. Nelson, R. W.; Krone, J. R.; Bieber, A. L.; Williams, P. Mass spectrometric immunoassay Anal. Chem. 1995, 67 (7) 1153-1158
11. Ackermann, B. L.; Berna, M. J. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers Expert Rev. Proteomics 2007, 4, 175-186 (Pubitemid 46588454)
12. Makawita, S.; Diamandis, E. P. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification Clin. Chem. 2010, 56 (2) 212-222
13. Brewis, I. A.; Brennan, P. Proteomics technologies for the global identification and quantification of proteins Adv. Protein Chem. Struct. Biol. 2010, 80, 1-44
14. Ly, L.; Wasinger, V. C. Protein and peptide fractionation, enrichment and depletion: tools for the complex proteome Proteomics 2011, 11 (4) 513-534
15. Lopez, M. F.; Rezai, T.; Sarracino, D. A.; Prakash, A.; Krastins, B.; Athanas, M.; Singh, R. J.; Barnidge, D. R.; Oran, P.; Borges, C.; Nelson, R. W. Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants Clin. Chem. 2010, 56, 281-290
16. Li, Y.; Tian, Y.; Rezai, T.; Prakash, A.; Lopez, M. F.; Chan, D. W.; Zhang, H. Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues Anal. Chem. 2011, 83, 240-245
17. Fredolini, C.; Tamburro, D.; Gambara, G.; Lepene, B. S.; Espina, V.; Petricoin, E. F., 3rd; Liotta, L. A.; Luchini, A. Nanoparticle technology: amplifying the effective sensitivity of biomarker detection to create a urine test for hGH Drug Test Anal. 2009, 9-10) 447-454
18. Drabovich, A. P.; Jarvi, K; Diamandis, E. P. Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay Mol. Cell. Proteomics 2011, 10 M110.004127
19. Liu, A. Y.; Zhang, H.; Sorensen, C. M.; Diamond, D. L. Analysis of prostate cancer by proteomics using tissue specimens J. Urol. 2005, 173, 73-78 (Pubitemid 39627676)
20. Zhang, H.; Liu, A. Y.; Loriaux, P.; Wollscheid, B.; Zhou, Y.; Watts, J. D.; Aebersold, R. Mass spectrometric detection of tissue proteins in plasma Mol. Cell. Proteomics 2007, 6, 64-71 (Pubitemid 46152692)
21. Fredolini, C; Meani, F; Reeder, K. A.; Rucker, S; Paanarut, A; Botterell, P. J.; Bishop, B; Longo, C; Espina, V; Petricoin, E. F.; Liotta, L. A.; Luchini, A. Concentration and preservation of very low abundance biomarkers in urine, such as human growth hormone (hGH), by Cibacron Blue F3G-A loaded hydrogel particles Nano Res. 2008, 1, 502-518
22. Luchini, A; Geho, D. H.; Bishop, B; Tran, D; Xia, C; Dufour, R. L.; Jones, C. D.; Espina, V; Patanarut, A; Zhou, W; Ross, M. M.; Tessitore, A; Petricoin, E. F.; Liotta, L. A. Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation Nano Lett. 2008, 8 (1) 350-361 (Pubitemid 351177827)
23. Russo, P; Rezai, T; Prakash, A; Lopez, M. F.; Tamburro, D; Fredolini, C; Luchini, A; Liotta, L. A.; Petricoin, E. F. Human growth hormone quantititation in urine by isoform ratio analysis using nanoparticle capture/multiple reaction monitoring-mass spectrometry. ASMS 2011, not supplied.
24. Kote-Jarai, Z.; Amin, A.l.; Olama, A.; Leongamornlert, D.; Tymrakiewicz, M.; Saunders, E.; Guy, M.; Giles, G. G.; Severi, G.; Southey, M.; Hopper, J. L.; Sit, K. C.; Harris, J. M.; Batra, J.; Spurdle, A. B.; Clements, J. A.; Hamdy, F.; Neal, D.; Donovan, J.; Muir, K.; Pharoah, P. D.; Chanock, S. J.; Brown, N.; Benlloch, S.; Castro, E.; Mahmud, N.; O'Brien, L.; Hall, A.; Sawyer, E.; Wilkinson, R.; Easton, D. F.; Eeles, R. A. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript Hum. Genet. 2011, 6) 687-694
25. Penney, K. L.; Schumacher, F. R.; Kraft, P.; Mucci, L. A.; Sesso, H. D.; Ma, J.; Niu, Y.; Cheong, J. K.; Hunter, D. J.; Stampfer, M. J.; Hsu, S. I. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels Carcinogenesis 2011, 32 (6) 853-859
26. Sherwood, C. A.; Eastham, A.; Lee, L. W.; Risler, J.; Mirzaei, H.; Falkner, J. A.; Martin, D. B. Rapid optimization of MRM-MS instrument parameters by subtle alteration of precursor and product m/z targets J. Proteome Res. 2009, 8 (7) 3746-3751
27. Batruch, I.; Lecker, I.; Kagedan, D.; Smith, C. R.; Mullen, B. J.; Grober, E.; Lo, K. C.; Diamandis, E. P.; Jarvi, K. A. Proteomic analysis of seminal plasma from normal volunteers and post-vasectomy patients identifies over 2000 proteins and candidate biomarkers of the urogenital system J. Proteome Res. 2011, 10 (3) 941-953
28. Drabovich, A. P.; Diamandis, E. P. Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins J. Proteome Res. 2010, 9 (3) 1236-1245
29. Sturgeon, C. M.; Sprague, S. M.; Metcalfe, W. Variation in parathyroid hormone immunoassay results-a critical governance issue in the management of chronic kidney disease Nephrol. Dial. Transplant. 2011, 26, 3440-3445
30. Sturgeon, C. M.; Seth, J. Why do immunoassays for tumour markers give differing results? A view from the UK National External Quality Assessment Schemes Eur. J. Clin. Chem. Clin. Biochem. 1996, 34, 755-759 (Pubitemid 26319137)
31. Hoofnagle, A. N.; Becker, J. O.; Oda, M. N.; Cavigiolio, G.; Mayer, P.; Vaisar, T. Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures Clin Chem. 2012, 58 (4) 777-781
32. Lopez, M. F.; Kuppusamy, R.; Sarracino, D. A.; Prakash, A.; Athanas, M.; Krastins, B.; Rezai, T.; Sutton, J. N.; Peterman, S; Nicolaides, K. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester trisomy 21 maternal serum J. Proteome Res. 2011, 10 (1) 133-142
33. Boja, E. S.; Rodriguez, H. The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science Korean J. Lab. Med. 2011, 1 (2) 61-71
34. Van Eyk, J. E. Overview: the maturing of proteomics in cardiovascular research Circ. Res. 2011, 108 (4) 490-498
35. Wells, L.; Hart, G. W. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar FEBS Lett. 2003, 546, 154-58 (Pubitemid 36782297)
36. Shen, F.; Kirmani, K. Z.; Xiao, Z; Thirlby, B. H.; Hickey, R. J.; Malkas, L. H. Nuclear protein isoforms: implications for cancer diagnosis and therapy J. Cell. Biochem. 2011, 112 (3) 756-60
37. Emami, N.; Diamandis, E. P. Human tissue kallikreins: a road under construction Clin. Chim. Acta 2007, 381 (1) 78-84 (Pubitemid 46719134)
38. Niesler, B. 5-HT(3) receptors: potential of individual isoforms for personalised therapy Curr. Opin. Pharmacol. 2011, 11 (1) 81-86
39. Hein, D. W. N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine Expert Opin. Drug Metab. Toxicol. 2009, 5 (4) 353-66
40. Danser, A. H.; Batenburg, W. W.; van den Meiracker, A. H.; Danilov, S. M. ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition? Pharmacol. Ther. 2007, 113 (3) 607-618 (Pubitemid 46365959)
41. Black, J. L., 3rd; O'Kane, D. J.; Mrazek, D. A. The impact of CYP allelic variation on antidepressant metabolism: a review Expert Opin. Drug Metab. Toxicol. 2007, 3 (1) 21-31 (Pubitemid 47307454)
42. Reymond, M. A.; Steinert, R.; Kähne, T.; Sagynaliev, E.; Allal, A. S.; Lippert, H. Expression and functional proteomics studies in colorectal cancer Pathol. Res. Pract. 2004, 200 (2) 119-127 (Pubitemid 38950441)
43. Calvo, E.; Camafeita, E.; Fernández-Gutiérrez, B.; López, J. A. Applying selected reaction monitoring to targeted proteomics Expert Rev. Proteomics. 2011, 8 (2) 165-173
44. Picotti, P.; Rinner, O.; Stallmach, R.; Dautel, F.; Farrah, T.; Domon, B.; Wenschuh, H.; Aebersold, R. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes Nat. Methods 2010, 7 (1) 43-46
45. Pernemalm, M.; Lewensohn, R.; Lehtiö, J. Affinity prefractionation for MS-based plasma proteomics Proteomics 2009, 9 (6) 1420-1427
46. Becker, C. H.; Bern, M. Recent developments in quantitative proteomics Mutat. Res. 2011, 722 (2) 171-182